The Safety and Effectiveness of Infliximab Biosimilar in Managing Rheumatoid Arthritis: A Real-Life Experience from Jordan.
Khaldoon M AlawnehAbdel-Hameed W Al-MistarehiAli QandeelRuba JaberSafwan AlomariKhalid Ahmed KheirallahPublished in: International journal of clinical practice (2022)
IFX biosimilar demonstrated safety and effectiveness in managing RA patients bringing real-world clinical support for biosimilars' role in rheumatology.
Keyphrases
- rheumatoid arthritis
- randomized controlled trial
- end stage renal disease
- systematic review
- ejection fraction
- newly diagnosed
- chronic kidney disease
- disease activity
- ankylosing spondylitis
- prognostic factors
- interstitial lung disease
- patient reported outcomes
- juvenile idiopathic arthritis
- systemic sclerosis
- ulcerative colitis